CPMV — Mosaic Immunoengineering Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Mosaic Immunoengineering, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.68 | -2.38 | -1.01 | -0.922 | -0.688 |
| Non-Cash Items | 1.49 | 0.046 | -0.369 | 0.08 | 0.073 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.52 | 1.64 | 0.879 | 0.601 | 0.503 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -0.679 | -0.69 | -0.497 | -0.241 | -0.111 |
| Other Investing Cash Flow Items | 0.028 | 0.343 | 0.433 | 0 | — |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.028 | 0.343 | 0.433 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.525 | 0.342 | 0 | 0.2 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.127 | -0.005 | -0.064 | -0.041 | -0.111 |